NuShores Biosciences, LLC (NuShores), founded in 2014, was formed to commercialize patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock from over $12 million in grant research to date.
We have recruited nationally recognized business, technology and medical experts for advisors, directors, and future senior executives.
In severe fractures and deficits, bone fillers or cements are used to help bridge the fractured bone and promote healing; however, their contribution to the healing process is limited.  Orthopedic appliances may be needed for extra support in early stages of healing. Natural or synthetic bone grafts have drawbacks and limitations — using either an autograft (patient’s own bone via an additional painful procedure) or allografts (cadaveric donor bone); both are complicated procedures that can require long recovery periods. Shortages exist in availability of donor tissue traditionally used in such reconstructions and the size of these grafts is limited. Â
 Â
The components used to construct our devices have received clearance from the FDA for use in other devices or are in process of clearance. In situ, the implant swells to lock into place in the bone defect, eliminating the need for special instruments to secure the graft in place. It does not result in aberrant growth. The scaffold is hydrophilic.
NuCressâ„¢ scaffolds in research shows that it is effective and safe and substantially equivalent to other marketplace offerings for the same indications for bone void fillers.
A pipeline of NuCressâ„¢ bone fillers is under development to be used beyond extremities; initial data has been generated in lumbar spinal fusion, dental implants and craniomaxillofacial applications.
The NuCressâ„¢ design reduces the need for autografts and allografts using a controlled porosity polymeric scaffold embedded with smaller amounts of DMB and HA.
We are committed to improve the life of people with severe tissue regeneration needs and conditions.
We are committed to working collaboratively with institutions of higher education, medical hospitals, and strategic partners to bring our disruptive technologies to market so as to achieve the greater good of improving lives to people in need.
To positively impact our community and the world
It is a rare opportunity to be able to support the historic scientific discoveries licensed to NuShores from UA Little Rock that will have a significant positive impact on public health and clinical practices. Â I am blessed to be able to participate with NuShores team in maturing such scientific breakthroughs to commercial success
I am honored to serve on the advisory board for NuShores Biosciences LLC. I look forward to opportunities to contribute to your efforts with my experience and lessons learned in the areas of science – technology planning and commercialization, and to assist in the clinical aspects to make it available to patients as soon as possible.
I am pleased to serve on the NuShores’ Advisory Board and look forward to contributing to their venture’s product successes. There is a need for their innovative NuCress™ bone void filler that has potential use in my areas of medical practice. I look forward to working with the NuShores team in accomplishing the scientific, regulatory and development milestones to make such a product available to physicians and their patients
I am delighted to be working with such a wonderful team on lifechanging technologies and applications. It is an honor to be along for the journey.
The opportunity to serve on the board of NuShores is exciting and thought-provoking. As an active member of the scientific community with a specific interest in orthopedics, the ongoing research is especially relevant and exciting for me.  I am delighted to have to opportunity to help such a robust and creative group move their technology and research efforts forward
I am very excited to work with the team at NuShores in the development of an enabling technology in tissue regeneration. I have worked with the group for some time now and have the greatest respect for their approach to the challenge and the quality of their research. I believe that the rigor behind their work is world class and will be regarded as a new standard of care in repairing bone loss.
The NuShores group has assembled a very strong development team under Dr. Biris and the operational depth needed to bring their novel materials to the market. I am very excited to be contributing to NuShores and Alex’ team.
Founder and Advisor
Andrew G. Kumpuris, MD is founder, investor and Advisor of NuShores. He recently retired as a Cardiology Specialist with 50 years of experience in the medical field. A widely known and respected community leader and organizer, Dr. Kumpuris has served and continues to serve in diverse business and community boards and has held several distinguished academic and healthcare policy positions throughout his career.
Advisor
Dr. Barnes is widely recognized as one of the foremost joint replacement experts in the nation. He currently serves as Professor and as The Carl L. Nelson, M.D. Distinguished Chair in Orthopaedic Surgery at UAMS
Advisor
Dr. James Y. Suen is a Professor and Chairman of the Department of Otolaryngology - Head and Neck Surgery at University of Arkansas Medical Sciences (UAMS)
Founder and Advisor
David E Anderson, DVM, MS, Diplomate American College of Veterinary Surgeons. Â Dr. Anderson is a co-founder of Nushores Biosciences LLC. He is also Associate Dean for Research and Graduate Studies, College of Veterinary Medicine, University of Tennessee, Knoxville.
Advisor
Dr. Douglas is Executive Director of the Texas Life Science Collaboration Center
Advisor
Larry J. Suva PhD, is a professor at Texas A&M University College of Veterinary Medicine and Biomedical Sciences and department head of Veterinary Physiology and Pharmacology
Strategic Advisor
Jeff Skiba has more than 30 years experience in leading medical device development and commercialization of first-to-market concepts.
Founder / CTO
Dr. Alexandru S. Biris is Co-Founder and Chief Technology Officer of Nushores Biosciences LLC
© 2025 —NuShores Biosciences LLC